Article in Animal Pharm nov 23
Link (locked article) >> Redistributed with permission from Animal Pharm Panion targets gene therapy pilot study in North America Panion Animal Health will soon enter a pilot study for its canine epilepsy drug candidate. The Swedish company is developing a gene therapy and recently gained positive safety results following the clinical phase of its treatment study In a statement regarding the firm’s third-quarter and nine-month results, Anja Holm – chief